Thymoquinone induces apoptosis through downregulation of c-FLIP and Bcl-2 in Renal carcinoma Caki cells

Oncology Reports

Volumn 36, Issue 4, 2016, Pages 2261-2267

  Park, Eun Jung ^a   Chauhan, Anil Kumar ^a   Min, Kyoung Jin ^a   Park, Dong Cheol ^b   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

^b Gimcheon University   (South Korea)

Author keywords

Apoptosis; Bcl 2; C FLIP; Renal cell carcinoma; Thymoquinone

Indexed keywords

CYTOCHROME C; FLICE INHIBITORY PROTEIN; MESSENGER RNA; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THYMOQUINONE; BENZOQUINONE DERIVATIVE; CFLAR PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME REGULATION; KIDNEY CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; BIOSYNTHESIS; CARCINOMA, RENAL CELL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BENZOQUINONES; CARCINOMA, RENAL CELL; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; CYTOCHROMES C; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 84984940619     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5019     Document Type: Article

References (31)

1. Hodorová I, Rybárová S, Solár P, Vecanová J, Mihalik J, Bohus P, Mellová Y and Kluchová D: Multidrug resistance proteins in renal cell carcinoma. Folia Biol 54:187-192, 2008.
2. Motzer RJ, Russo P, Nanus DM and Berg WJ: Renal cell carcinoma. Curr Probl Cancer 21:185-232, 1997.
3. Rini BI and Atkins MB: Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10:992-1000, 2009.
4. Park EJ, Min KJ, Choi KS and Kwon TK: Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner. Exp Cell Res 323:144-154, 2014.
5. Han MA, Woo SM, Min KJ, Kim S, Park JW, Kim DE, Kim SH, Choi Y H and Kwon TK: 6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP (L) expression. Chem Biol Interact 228:69-78, 2015.
6. Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, et al: Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med 369:722-731, 2013.
7. Keisner SV and Shah SR: Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma. Drugs 71:443-454, 2011.
8. Gotink KJ, Rovithi M, de Haas RR, Honeywell RJ, Dekker H, Poel D, Azijli K, Peters GJ, Broxterman HJ and Verheul HM: Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib. Cell Oncol 38:119-129, 2015.
9. Juengel E, Kim D, Makarevic J, Reiter M, Tsaur I, Bartsch G, Haferkamp A and Blaheta RA: Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib. J Cell Mol Med 19:430-441, 2015.
10. Salomi MJ, Nair SC and Panikkar KR: Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer 16:67-72, 1991.
11. Tiruppur Venkatachallam SK, Pattekhan H, Divakar S and Kadimi US: Chemical composition of Nigella sativa L. seed extracts obtained by supercritical carbon dioxide. J Food Sci Technol 47:598-605, 2010.
12. Lei X, Lv X, Liu M, Yang Z, Ji M, Guo X and Dong W: Thymoquinone inhibits growth and augments 5-fluorouracilinduced apoptosis in gastric cancer cells both in vitro and in vivo. Biochem Biophys Res Commun 417:864-868, 2012.
13. Gali-Muhtasib H, Roessner A and Schneider-Stock R: Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 38:1249-1253, 2006.
14. Mi Y, Zhang C, Bu Y, Zhang Y, He L, Li H, Zhu H, Li Y, Lei Y and Zhu J: DEPDC1 is a novel cell cycle related gene that regulates mitotic progression. BMB Rep 48:413-418, 2015.
15. Seo K, Ki SH and Shin SM: Methylglyoxal induces mitochondrial dysfunction and cell death in liver. Toxicol Res 30:193-198, 2014.
16. Wong RS: Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res 30:87, 2011.
17. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS and Buttyan R: Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55:4438-4445, 1995.
18. Shirley S and Micheau O: Targeting c-FLIP in cancer. Cancer Lett 332:141-150, 2013.
19. Wilkie-Grantham RP, Matsuzawa S and Reed JC: Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein. J Biol Chem 288:12777-12790, 2013.
20. Willis S, Day CL, Hinds MG and Huang DC: The Bcl-2-regulated apoptotic pathway. J Cell Sci 116:4053-4056, 2003.
21. Czabotar PE, Lessene G, Strasser A and Adams JM: Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49-63, 2014.
22. Labi V, Grespi F, Baumgartner F and Villunger A: Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: A breakthrough in anticancer therapy? Cell Death Differ 15:977-987, 2008.
23. Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, et al: Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206:123-134, 2005.
24. Catz SD and Johnson JL: Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20:7342-7351, 2001.
25. Heckman CA, Mehew JW and Boxer LM: NF-kappaB activates Bcl-2 expression in t (14;18) lymphoma cells. Oncogene 21:3898-3908, 2002.
26. Tang S, Hu J, Meng Q, Dong X, Wang K, Qi Y, Chu C, Zhang X and Hou L: Daidzein induced apoptosis via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway in BGC-823 cells. Cell Biochem Biophys 65:197-202, 2013.
27. Chen QY, Lu GH, Wu YQ, Zheng Y, Xu K, Wu LJ, Jiang ZY, Feng R and Zhou JY: Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep 23:1285-1292, 2010.
28. Slimen IB, Najar T, Ghram A, Dabbebi H, Ben Mrad M and Abdrabbah M: Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia 30:513-523, 2014.
29. Fleury C, Mignotte B and Vayssière JL: Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84:131-141, 2002.
30. Cai J, Yang J and Jones DP: Mitochondrial control of apoptosis: The role of cytochrome c. Biochim Biophys Acta 1366:139-149, 1998.
31. Banjerdpongchai R, Kongtawelert P, Khantamat O, Srisomsap C, Chokchaichamnankit D, Subhasitanont P and Svasti J: Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells. J Hematol Oncol 3:50, 2010.